In Bankruptcy, Amyris To Sell Consumer Brands, Turn Focus To Smaller Ingredients Business
Synthetic biotech company Amyris files for Chapter 11 bankruptcy for its multiple US corporate entities and plans to sell its consumer brands.
Synthetic biotech company Amyris files for Chapter 11 bankruptcy for its multiple US corporate entities and plans to sell its consumer brands.